Latest
Vaccines and AMR: Strengthening the Fight
To coincide with World Immunization Week, IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.
Pharm Exec's Emerging Pharma Leaders 2018 Call for Nominations
Read more for details of how to nominate a colleague or yourself for Pharm Exec's Emerging Pharma Leaders 2018.
Patient Adherence and Human Nature
We need to look to behavioral science to deconstruct the psychological barriers that make patients act in ways that can seem irrational and self-defeating, writes Jim O'Donoghue.
South Florida Delivers on Pharma-Friendly Distribution
This article discusses the supply chain benefits of pharma companies distributing from South Florida.
PharmExec Videos
New & Noteworthy
Atopic Dermatitis — Going Beyond the Pill
There is a real opportunity for pharma to support the under-served population of atopic dermatitis patients, writes Mariel Metcalfe.
3 Behavioral Biases that Stunt the Potential of Marketers
As marketers mine for insights, they need to be keenly aware of the behavioral biases that can undermine their efforts, writes Kunsan Kim.
Rewriting Pharma’s Talent Blueprint
Amid rapid shifts in technology and consumer engagement, Lisa Henderson explores how new models in hiring and recruitment are reshaping biopharma’s future talent path.
Planning for Post-Deal Integration
Jo Pisani and Cynthia Chan outline the key legal considerations for post-deal integration.
HEOR Education: Evolving the Skill Set
Practitioners in the field of HEOR training and education outline how the best courses are responding to advancing industry needs. Julian Upton reports.
Sales & Marketing
3 Behavioral Biases that Stunt the Potential of Marketers
As marketers mine for insights, they need to be keenly aware of the behavioral biases that can undermine their efforts, writes Kunsan Kim.
Improving Persistence: Brand Team Dos and Don'ts
In Part 4 of a 4-part series on brand teams, this article discusses the tactics brand teams and partners should follow to improve medication and persistence.
Drug Marketing and Advertising Under Fire
FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion.
eBooks
Emerging BioPharma: Your Guide to Clinical and Commercial Considerations
This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways.
PEspeaks
Cognitive Pharmacovigilance Intake—Elementary My Dear Watson? Not So Fast
This blog post focuses on digital process automation challenges of PV Intake, with an emphasis on the elements required to fully process an ICSR and influence upstream adverse event case processing (AECP) through the application of digital automation.
Biosimilars in China
Jin Zhang discusses the research and development of several major biologics in China.
Moving Scientists from the Lab to the Executive Suite
This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.
The New Talent Trajectory
Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.
Emerging Pharma Leaders
Compliance Top of Mind
There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.
Interviews
Vaccines and AMR: Strengthening the Fight
To coincide with World Immunization Week, IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.
HBA's Woman of the Year 2018
Julie Gerberding, this year's Healthcare Businesswomen’s Association Woman of the Year, has remained steadfast in her life’s mission—help the many, help the one.
Growth in the Time of Brexit: James Burt, Accord Healthcare
James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.
Regulatory
Drug Marketing and Advertising Under Fire
FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion. Jill Wechsler reports.
Mega Budget Bill Boosts Funding for Biomedical Research, FDA programs
After months of delay, Congress finally passed a $1.3 trillion omnibus budget bill March 22, 2018, just in time to avoid another government shut-down.
FDA’s Gottlieb Hits Innovators, Insurers for Blocking Biosimilar Uptake
As part of FDA initiatives to reward innovation and promote patient access to medicines, the agency is working hard to support the development of high quality biosimilars and interchangeable products, Scott Gottlieb told a conference on March 7.
From the Editor
The New Talent Trajectory
Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.
The Law of Unintended Consequences
Tackling some of the unintended consequences associated with value-based contracting in pharma and efforts to advance toward sustainable outcomes-based engagement.
|
|---|
|
Sponsored Links
Global
Biosimilars in China
Jin Zhang discusses the research and development of several major biologics in China.
ANDA Approvals Boost Chinese Pharma's Global Ambitions
Jin Zhang looks at the Chinese pharma companies that received FDA ANDA approvals in 2017 and discusses how the country's industry is poised for further breakthrough.
Plus ça change...
Looking back at the agenda of a 1985 EFPIA conference, Reflector sees that, three decades on, the European drug industry is still seeking a pill for its own ills.
Four Key Areas Shaping the Chinese Pharma Industry
Jin Zhang outlines four key areas that impacted Chinese pharma in 2017 and looks at how their effects will shape the industry in the years ahead.
Strategy
Med Affairs Building Up its Strategic Muscle
The role of the medical affairs professional in the biopharma hierarchy has grown considerably, but challenges remain in its ascent to true strategic partner with the C-suite, writes Lisa Henderson.
Taking Command of Strategy Execution
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years.
Engaging in Risk-Sharing Agreements with Providers
Before entering into risk-sharing agreements, manufacturers must understand the challenges and implications, writes Kimberly E. White.
Technology
A Watchful Eye on AI
Looking at the balance of optimism and caution discussed at eyeforpharma Barcelona around pharma’s embrace of AI.
The New (Augmented) Reality in the Life Sciences
Three ways AR can bolster pharma commercialization strategies. Arno Sosna reports.
Delivering Value from Data Analytics
For companies that overcome the challenges, there is tremendous opportunity to drive sustainable growth through technology and analytics-driven business innovation, writes Vita Cassese.
